Trial
NCT03069989
Single Doses of GSK3008348 in Idiopathic Pulmonary Fibrosis (IPF) Participants Using Positron Emission Tomography (PET) Imaging
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
GlaxoSmithKline
Collaborators
—
Condition
Idiopathic Pulmonary Fibrosis
Intervention
GSK3008348
Why stopped
Sufficient information was gathered from cohort 1 to terminate the study without proceeding to optional cohort 2.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-08-12